<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(2)</volume><submitter>Bugalho M</submitter><pubmed_abstract>The author responds to comments on the study published by Ravaud et al. in The Oncologist on sunitinib for medullary thyroid carcinoma.</pubmed_abstract><journal>The oncologist</journal><pagination>214-214</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3227934</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>In Reply</pubmed_title><pmcid>PMC3227934</pmcid><pubmed_authors>Bugalho M</pubmed_authors></additional><is_claimable>false</is_claimable><name>In Reply</name><description>The author responds to comments on the study published by Ravaud et al. in The Oncologist on sunitinib for medullary thyroid carcinoma.</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Feb</publication><modification>2025-06-01T12:14:34.539Z</modification><creation>2019-03-27T00:46:34Z</creation></dates><accession>S-EPMC3227934</accession><cross_references/></HashMap>